Liaoning Chengda Biotechnology Co., Ltd. (SHSE: 688739)
Health Care · Biotechnology · CN
CN¥21.02
+1.94% today · -22.6% 1Y
Liaoning Chengda Biotechnology Co., Ltd. (SHSE: 688739) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.29B.
Over the last twelve months the share price has lost 22.6%, trading between 18.91 and 28.43.
Tweenvest scores Liaoning Chengda Biotechnology Co., Ltd. across four factors: quality 75/100, value 30/100, growth 0/100, dividend 82/100. Its strongest factor is dividend.
688739 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.29B
- Revenue (TTM)
- $200.33M
- P/E
- 204.43
- EPS
- 0.10
- Dividend yield
- 0.48%
- Beta (5Y)
- 0.42
- 52-week high
- CN¥28.43
- 52-week low
- CN¥18.91
- Avg volume (3M)
- —
- Shares outstanding
- 410.81M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Pharma Mar, S.A.BME: PHM | $1.33B | €68.60 | -1.65% |
| Vcanbio Cell & Gene Engineering Corp., LtdSHSE: 600645 | $1.32B | CN¥19.41 | +3.58% |
| Vitrolife AB (publ)OM: VITR | $1.30B | Skr93.10 | -3.32% |
| Bio-Thera Solutions, Ltd.SHSE: 688177 | $1.30B | CN¥21.03 | +0.96% |
| Everest Medicines LimitedSEHK: 1952 | $1.28B | HK$28.64 | +3.39% |
| Damora Therapeutics, Inc.NasdaqCM: DMRA | $1.27B | $20.56 | -0.44% |
| Nanobiotix S.A.ENXTPA: NANO | $1.27B | €22.34 | -0.89% |
| ORIC Pharmaceuticals, Inc.NasdaqGS: ORIC | $1.27B | $12.03 | -1.43% |
Figures last refreshed Oct 4, 2026.